What is SOPHiA Genetics SA Annual Revenue?

SOPHiA Genetics SA Annual Revenue rose 4.49%, in the last year to $65.17 M. Its sector's average revenue growth for the last fiscal year was 4.38%.

What is SOPHiA Genetics SA Annual Net Profit?

SOPHiA Genetics SA Annual Net Profit rose 20.88% in the last year to $62.49 M. Its sector's average net profit growth for the last fiscal year was 20.39%.

What is SOPHiA Genetics SA Price to Earning Ratio?

SOPHiA Genetics SA Price to Earning Ratio is -2.95, which is negative.

What is SOPHiA Genetics SA Stock Price?

SOPHiA Genetics SA Stock Price fell 43.67% and underperformed its sector by 43.81% in the past year.

What is SOPHiA Genetics SA Quarterly Revenue?

SOPHiA Genetics SA Quarterly Revenue rose 4.02% YoY to $17.73 M. Its sector's average revenue growth YoY for the quarter was 8%.

What is SOPHiA Genetics SA Quarterly Net profit?

SOPHiA Genetics SA Quarterly Net profit rose 37% YoY to $15.16 M. Its sector's average net profit growth YoY for the quarter was 48.49%.

What is SOPHiA Genetics SA Debt to Equity Ratio?

SOPHiA Genetics SA Debt to Equity Ratio of 0.31 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is SOPHiA Genetics SA Return on Equity(ROE)?

SOPHiA Genetics SA Return on Equity(ROE) for the last financial year was -50.41%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is SOPHiA Genetics SA Mutual Fund Holding?

SOPHiA Genetics SA Mutual Fund Holding increased by 0.05% in the last quarter to 6.43.

What is SOPHiA Genetics SA Interest Coverage Ratio?

SOPHiA Genetics SA Interest Coverage Ratio is -31.03, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is SOPHiA Genetics SA Institutional Holding?

SOPHiA Genetics SA Institutional Holding remained the same in the last quarter at 30.27%.

How is the SOPHiA Genetics SA today?

The SOPHiA Genetics SA today is trading in the down by -8.00% at 2.76.

How has SOPHiA Genetics SA performed historically?

The SOPHiA Genetics SA is currently trading down -8.00% on an intraday basis in the past week the index fell -15.34%. The index has been down -15.34% in the past quarter and fell -43.67% in the past year. You can view this in the overview section.

SOPHiA Genetics SA XNAS: SOPH

SOPHiA Genetics SA Live Share Price Today, Share Analysis and Chart

Name: SOPHiA Genetics SA: Is Infosys Ltd. worth buying?
Item: SOPHiA Genetics SA
Rating: 1.008833375
Author: Trendlyne DVM scores

Weak Stock

Download real time

2.76 -0.24 (-8.00%)

New 52W Low today

82,838 XNAS Volume

High volume+loss today

XNAS 04 Apr, 2025 5:30 PM (EDT)

SOPHiA Genetics SA Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	184.5
PE TTM Negative PE TTM Unavailable in chosen country	-3
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.1
Price to Book Below industry Median Unavailable in chosen country	1.9
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	30.3
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	4
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	4.5
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	37
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	20.9
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-98.4
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-102.1
Piotroski Score Low in industry Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	0.5
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-50.4
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-34.6

All financials are in USD Million and price data in USD

Low Financial Strength

16.7 / 100

Expensive Valuation

17.8 / 100

Technically Bearish

29.5 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 146%

5 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

SOPHiA Genetics SA Stock Price Analysis

Day Price Range -8.0% 1 Day return Unavailable in chosen country	2.8 (LTP) 2.73.3 LowHigh
Week Price Range -15.3% 1 Week return Unavailable in chosen country	2.8 (LTP) 2.73.5 LowHigh
Month Price Range -11.0% 1 Month return Unavailable in chosen country	2.8 (LTP) 2.73.8 LowHigh
52 Week Price Range -43.7% 1 Year return Unavailable in chosen country	2.8 (LTP) 2.76.3 LowHigh

View full Share Price History

SOPHiA Genetics SA Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

SOPHiA Genetics SA's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.9

Avg. Estimate

-0.9

Low Estimate

-1

High Estimate

-0.8

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 6.3% in FY25

Consensus Recommendation

6 ANALYST Recommendations

BUY

The consensus recommendation from 6 analysts for SOPHiA Genetics SA is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

SOPHiA Genetics SA Stock Analysis

SOPHiA Genetics SA stock analysis with key metrics, changes, and trends.

SOPHiA Genetics SA Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$65.17 M	4.49%	positive	Annual Revenue rose 4.49%, in the last year to $65.17 M. Its sector's average revenue growth for the last fiscal year was 4.38%.
Annual Net Profit	$62.49 M	20.88%	positive	Annual Net Profit rose 20.88% in the last year to $62.49 M. Its sector's average net profit growth for the last fiscal year was 20.39%.
Price to Earning Ratio	-2.95	-	negative	Price to Earning Ratio is -2.95, which is negative.
Stock Price	$2.76	-43.67%	negative	Stock Price fell 43.67% and underperformed its sector by 43.81% in the past year.
Quarterly Revenue	$17.73 M	4.02%	positive	Quarterly Revenue rose 4.02% YoY to $17.73 M. Its sector's average revenue growth YoY for the quarter was 8%.
Quarterly Net profit	$15.16 M	37%	positive	Quarterly Net profit rose 37% YoY to $15.16 M. Its sector's average net profit growth YoY for the quarter was 48.49%.
Debt to Equity Ratio	0.31	-	positive	Debt to Equity Ratio of 0.31 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-50.41 %	-50.41%	negative	Return on Equity(ROE) for the last financial year was -50.41%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	6.43 %	0.05%	positive	Mutual Fund Holding increased by 0.05% in the last quarter to 6.43.
Interest Coverage Ratio	-31.03	-	negative	Interest Coverage Ratio is -31.03, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	30.27 %	0%	neutral	Institutional Holding remained the same in the last quarter at 30.27%.

VIEW LESS

Loading data..

SOPHiA Genetics SA - Company Profile

What does SOPHiA Genetics SA do?

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Gross Remuneration

2024

Gross Remuneration

Year

SOPHiA Genetics SA Live Share Price Today, Share Analysis and Chart

New 52W Low today

High volume+loss today

SOPHiA Genetics SA Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

SOPHiA Genetics SA Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

SOPHiA Genetics SA Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

SOPHiA Genetics SA's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 6.3% in FY25

Consensus Recommendation

The consensus recommendation from 6 analysts for SOPHiA Genetics SA is BUY

SOPHiA Genetics SA Stock Analysis

SOPHiA Genetics SA stock analysis with key metrics, changes, and trends.

Annual Revenue rose 4.49%, in the last year to $65.17 M. Its sector's average revenue growth for the last fiscal year was 4.38%.

Annual Net Profit rose 20.88% in the last year to $62.49 M. Its sector's average net profit growth for the last fiscal year was 20.39%.

Price to Earning Ratio is -2.95, which is negative.

Stock Price fell 43.67% and underperformed its sector by 43.81% in the past year.

Quarterly Revenue rose 4.02% YoY to $17.73 M. Its sector's average revenue growth YoY for the quarter was 8%.

Quarterly Net profit rose 37% YoY to $15.16 M. Its sector's average net profit growth YoY for the quarter was 48.49%.

Debt to Equity Ratio of 0.31 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -50.41%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.05% in the last quarter to 6.43.

Interest Coverage Ratio is -31.03, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding remained the same in the last quarter at 30.27%.

SOPHiA Genetics SA - Company Profile

What does SOPHiA Genetics SA do?

SOPHiA Genetics SA Management structure

Mr. George A. Cardoza

Chief Financial Officer

Dr. Jurgi Camblong, M.B.A.,PhD

Chief Executive Officer and Director

Mr. Ross Muken, B.Sc.

President

Mr. Daan van Well, L.L.M.

Chief Legal and Compliance Officer

Dr. Philippe Menu, M.B.A.,M.D.,PhD

Chief Medical Officer and Chief Product Officer

Ms. Manuela Da Silva Valente

Chief People Officer

SOPHiA Genetics SA Board of directors

Mr. Didier Hirsch, M. Sc.,M.S.